Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
First Financial Bancorp
FFBC
$3.45B
| $1.95M | ﹤0.01% |
99,246
+42,228
| +74% | +$904K |
|
3502
PUT
Madrigal Pharmaceuticals
MDGL
$12.3B
| $1.94M | ﹤0.01% |
+13,300
| New | +$2.5M |
|
|
CMAX
3503
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.94M | ﹤0.01% |
30,478
-22,025
| -42% | -$1.54M |
|
3504
CALL
Upstart Holdings
UPST
$2.83B
| $1.94M | ﹤0.01% |
67,900
+59,300
| +690% | +$2.38M |
|
3505
Red Rock Resorts
RRR
$3.37B
| $1.94M | ﹤0.01% |
47,244
-584,369
| -93% | -$26.4M |
|
|
CIM
3506
Chimera Investment
CIM
$963M
| $1.93M | ﹤0.01% |
118,120
+112,768
| +2,107% | +$1.98M |
|
3507
CALL
Shell
SHEL
$250B
| $1.93M | ﹤0.01% |
30,000
-146,600
| -83% | -$9.13M |
|
3508
Madison Square Garden
MSGS
$9.38B
| $1.92M | ﹤0.01% |
10,902
-7,591
| -41% | -$1.43M |
|
3509
PUT
UGI
UGI
$8.15B
| $1.92M | ﹤0.01% |
83,500
+48,000
| +135% | +$1.19M |
|
3510
FIGS
FIGS
$2.56B
| $1.91M | ﹤0.01% |
324,427
-1,040,345
| -76% | -$6.92M |
|
3511
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $1.91M | ﹤0.01% |
9,765
+4,042
| +71% | +$823K |
|
|
RC
3512
Ready Capital
RC
$302M
| $1.91M | ﹤0.01% |
+188,906
| New | +$2.08M |
|
3513
CION Investment
CION
$363M
| $1.91M | ﹤0.01% |
180,648
+164,232
| +1,000% | +$1.78M |
|
3514
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
| $1.91M | ﹤0.01% |
+25,948
| New | +$2.01M |
|
3515
CALL
Zentalis Pharmaceuticals
ZNTL
$360M
| $1.91M | ﹤0.01% |
95,000
+45,700
| +93% | +$1.16M |
|
3516
PUT
BHP
BHP
$242B
| $1.91M | ﹤0.01% |
+33,500
| New | +$1.96M |
|
3517
The Joint Corp
JYNT
$119M
| $1.9M | ﹤0.01% |
211,700
-312,921
| -60% | -$3.54M |
|
3518
CALL
AST SpaceMobile
ASTS
$17.4B
| $1.9M | ﹤0.01% |
+500,000
| New | +$2.02M |
|
3519
Omnicom Group
OMC
$24.2B
| $1.89M | ﹤0.01% |
25,425
+13,867
| +120% | +$1.14M |
|
|
NSTG
3520
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.89M | ﹤0.01% |
1,100,468
-482,346
| -30% | -$1.47M |
|
3521
Utah Medical Products
UTMD
$232M
| $1.89M | ﹤0.01% |
21,989
+5,633
| +34% | +$520K |
|
|
SILK
3522
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.89M | ﹤0.01% |
126,148
-437,926
| -78% | -$9.11M |
|
|
YMAB
3523
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.89M | ﹤0.01% |
346,916
+17,347
| +5% | +$101K |
|
3524
Kilroy Realty
KRC
$4.21B
| $1.89M | ﹤0.01% |
59,795
-297,121
| -83% | -$10.3M |
|
3525
iShares Latin America 40 ETF
ILF
$3.72B
| $1.89M | ﹤0.01% |
+73,816
| New | +$1.97M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.